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Abstract
Th is article analyses R&D, innovation and foreign trade activity of the chemical industry in the selected EU 
Member States. Th e paper examines the period from 2005 to 2015. Th e methodology is based on the appli-
cation of key indicators in order to provide objective conclusions on work productivity and eﬀ ectiveness of 
chemicals production and production of basic pharmaceutical products and preparations. Th e aim of this 
research is to analyse the European chemical industry from the aspect of R&D and innovation activity. Th e 
main research results include R&D, innovativeness, foreign trade activity results, the rank of technological 
position of the European chemical industry, and recommendations and proposals for enhancing innovation 
and international competitiveness.  
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Th is paper provides an overview of R&D and inno-
vation activity of the chemical industry in the EU 
Member States. Th e main reason for choosing the 
chemical industry is its continuous investment in 
R&D activity. Th e main characteristics of the chem-
ical industry are deﬁ ned in the ﬁ rst part of the pa-
per, while the second part analyses R&D, innovation 
and economic activity of the EU chemical industry 
enterprises. In general, the chemical industry has 
characteristics of medium- and high-technology 
sectors. Th e chemical industry, as the third larg-
est sector of the European manufacturing indus-
try, produces heterogeneous products based on 
diﬀ erent technical and scientiﬁ c aspects and R&D 
objectives. Th e chemical industry sector includes 
enterprises which are exclusively or primarily pro-
ducing by converting substances. Extractive indus-
try enterprises create added value to raw materials 
that are converted into chemicals. Th e main task 
of chemical industry enterprises is substitution of 
natural substances and/or production of new sub-
stances (Albach et al., 1996).
Th e chemical industry is divided into several main 
sectors. Th e ﬁ rst is the production of basic chemicals. 
Besides the pharmaceutical industry, it is important 
to mention the industry of ﬁ ne chemicals (complex, 
pure chemical substances that are part of the ﬁ nal 
product), industrial chemicals (detergents, cleaning 
products, varnishes, photography and photocopy 
developing chemicals), and special chemical produc-
tion (Albach et al., 1996). CEFIC (2012) categorizes 
the European chemical industry in the same way. 
According to CEFIC (2012), the European chemi-
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cal industry comprises the sector of basic chemicals, 
special chemicals, the pharmaceutical industry, and 
consumer chemicals. Basic chemicals include petro-
chemistry, its derivatives and basic inorganic chemi-
cals. Products of the basic chemical sector are being 
produced in large quantities and sold to other pro-
ducers in the chemical industry, and to other indus-
tries. Th ey are used as inputs for diﬀ erent industries, 
such as leather, textile, paper, plastic, pharmaceuti-
cal, and rubber industry (Bhat, Narayanan, 2009). 
On the other hand, special chemicals are produced 
for special market needs and in smaller quantities. 
Th ey include additives, adhesives, coatings, plastics, 
paint and ink, products for crop protection, dyes, 
pigments, etc. Th e pharmaceutical industry includes 
basic pharmaceutical production and pharmaceuti-
cal preparations, while consumer chemical sector 
covers products for ﬁ nal consumption (soaps, de-
tergents, perfumes, and cosmetics). One of the key 
characteristics of chemical industry enterprises is 
the fact that most of their output are intermediary 
products (approximately 65%) for ﬁ nal products of 
other industries (Albach et al., 1996). Albach et al. 
(1996) claim that the automotive and construction 
industry, as well as the agricultural sector are some of 
the key chemical industry consumers. CEFIC (2012) 
conﬁ rms the importance of mechanical, electric, tex-
tile, clothing and paper industry as some of the main 
creators of demand for chemical industry products. 
It should be noted that vertical integration marks the 
chemical industry, but is not represented in all seg-
ments (e.g. commodity chemicals – alcohol, acids, 
wax, solvents, etc.). Some of the main characteristics 
of the chemical industry also include high heteroge-
neity of products, great importance of innovation and 
R&D activity, capital intensity, concentrated market 
structure, and high level of energy dependency. An 
interesting fact is that the chemical industry con-
sumes almost one quarter of the produced output. 
However, the EU chemical industry is facing serious 
challenges: globalization, growing competitiveness 
of Asia, ﬂ oating exchange rate, higher raw material 
costs, along with regulation and standardization of 
the European Union legislation (Bezić et al., 2011). 
Th e paper is based on the hypothesis that it is pos-
sible to evaluate current export competitiveness and 
comparative advantages of the Croatian manufactur-
ing industry by analysing the trends and applying 
the indicators. Th e aim of the research is to evaluate 
economic and technological aspects of the selected 
European chemical industry enterprises from which 
it is possible to derive conclusions.
2. Analysis of foreign trade activity of EU 
chemicals 
Th e chemical industry has an important role in 
the economy and society of the European Union. 
Namely, the chemical industry is not only one of 
the leaders in creating additional value and jobs, but 
also the main net exporter of the European Union, 
which has a positive impact on macroeconomic ﬁ -
nancial growth, i.e. economic stability. Most of the 
data are collected from CIS1 and Eurostat, in which 
the data for some European countries are not fully 
available. Table 1 below shows the EU share of the 
global chemicals market in the period of twenty 
years in percentage and billions of euros.
Table 1 EU share of the global chemicals market
Year EU chemicals sales (€ bill.) World
World 
share %
1995 326 1,008 32.3%
1996 335 1,029 32.5%
1997 362 1,171 30.9%
1998 362 1,112 32.5%
1999 366 1,183 30.9%
2000 421 1,469 28.7%
2001 421 1,408 29.9%
2002 416 1,361 30.6%
2003 414 1,323 31.3%
2004 436 1,427 30.6%
2005 458 1,622 28.2%
2006 505 1,802 28.0%
2007 524 1,904 27.5%
2008 530 2,056 25.8%
2009 418 1,846 22.7%
2010 495 2,394 20.7%
2011 548 2,743 20.0%
2012 553 3,050 18.1%
2013 548 3,077 17.8%
2014 536 3,100 17.3%
2015 519 3,534 14.7%
Source: Ceﬁ c Chemdata International (2016)
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The first row in Table 1 presents the EU chemi-
cals sales in the period from 1995 to 2015, where 
it is evident that the sales have almost doubled, 
with highest sales in 2012 amounting to 553 bil-
lion euros. Sales of chemicals in the world record-
ed excellent results, from 1,008 billion euros in 
1995 to 3,534 billion euros ten years later. How-
ever, when we examine the third row, which pre-
sents the share of EU chemicals in the world, it is 
notable that the share has more than halved. The 
fast growth of Asian countries might be the rea-
son why the EU share of chemicals in the world 
has reduced so significantly while the sales con-
tinued to rise.
Th e strategic and economic importance of the Eu-
ropean chemical industry is illustrated in Table 2 
which presents imports, exports and trade balance 
of European chemical industry enterprises. (CEFIC, 
2016).










NAFTA 36.5 25.0 11.4 25.5%
Japan 5.1 5.8 -0.8 -1.8%
Latin 
America 10.4 3.3 7.1 15.9
Africa 11.5 3.4 8.1 18.0%
China 11.6 11.6 0.0 0.0%
Rest of 
Europe 35.3 25.8 9.5 21.2%
Asia 48.4 41.6 6.7 15.1%
Rest of 
world 4.6 2.7 1.9 4.3%
Source: Ceﬁ c Chemdata International (2016)
Table 2 presents competitiveness indicators such 
as extra EU exports, imports and the trade balance. 
However, the EU still has an important competi-
tive place in both world exports and imports. EU 
chemicals are leading in the world exports. When 
we look at the trade balance, the EU has the leading 
position which shows that, although Table 1 above 
shows extensive share reductions, the EU still has 
the best position in imports, exports and trade bal-
ance, which means that it has a great competitive 
role in the world chemical industry.
3. Research and development activity and 
innovation activity of the EU chemical 
industry
Investing in R&D activity, i.e. innovation, is one of 
the main prerequisites for the success of market-
oriented enterprises in certain sectors. In high-
technology based industries, such as biotechnology, 
pharmaceutical and IT industry, innovations are 
often radical. Successful investment in R&D activ-
ity and innovation are not an accidental result, but 
rather a well-planned and disciplined analytical 
process in the context of applied research. 
R&D activity (resulting from the innovation that 
“has become applicable”) has an impact on the 
growth of economic activity and share of most of 
the enterprises on the market. Market demand, 
the costs of human and material resources, invest-
ments in material assets and business environment 
of enterprises can become key factors of R&D, i.e. 
innovation activities of successful enterprises. 
Enterprise orientation towards R&D and innova-
tion results in higher eﬀ ectiveness of input-to-
output transformation and productivity enhance-
ment. Such productivity contributes to higher 
export competitiveness of the enterprise, which is 
manifested as a ﬁ nal result through market share 
growth, reduction of costs, and proﬁ t maximiza-
tion on a foreign market. Innovation integrated in 
competitors’ products might be an additional im-
pulse to investment growth in R&D activity of one’s 
own enterprise, especially in high-technology en-
terprises and medium-level technology industries 
(e.g. the chemical industry). More investments in 
R&D activity and innovation of certain industries 
bring economic beneﬁ ts for customers who re-
ceive products of higher quality and lower price. 
Table 3 below presents R&D in the EU chemical 
industry, i.e. shows how much the EU invests in 
R&D and the share of R&D in total sales. 
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Table 3 R&D in the EU chemical industry
EU28 R&D Spending (€ billion) Sales (€ billion) R&D spending (% sales)
1993 7.2 276.5 2.6%
1994 7.1 298.8 2.4%
1995 7.2 325.6 2.2%
1996 7.1 334.7 2.1%
1997 7.4 361.6 2.0%
1998 7.5 361.6 2.1%
1999 7.6 365.6 2.1%
2000 8.1 421.0 1.9%
2001 7.9 420.9 1.9%
2002 7.7 416.3 1.8%
2003 7.6 413.9 1.8%
2004 7.8 436.3 1.8%
2005 7.6 457.7 1.7%
2006 8.3 504.7 1.6%
2007 8.0 524.3 1.5%
2008 8.2 530.1 1.5%
2009 7.9 418.2 1.9%
2010 7.9 495.3 1.6%
2011 8.0 548.0 1.5%
2012 8.5 553.0 1.5%
2013 8.4 548.1 1.5%
2014 9.1 536.3 1.7%
2015 9.1 519.0 1.8%
Source: Ceﬁ c Chemdata International (2016)
R&D activity in the EU has been oscillating in the 
past ten years, but it has not increased with the 
sales; namely, the share of R&D in sales has almost 
halved and has only slightly increased over the last 
two years. EU chemical companies tend to invest 
less in R&D activity although the sales increase. 
In the framework of R&D analysis, it is necessary 
to examine separately intramural2 and extramural3 
R&D activity of European chemical industry enter-
prises. Table 4 and Table 5 present the number of 
European chemical industry enterprises and their 
R&D activity which includes technological and 
non-technological innovation (production, pro-
cess, marketing, organization)4. Th e reference year 
is 2010. In the framework of the analysis, the used 
data are based on NACE Rev. 2 classiﬁ cation.
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Table 4 Number of European chemical industry enterprises included in the implementation of intra-
mural R&D activity in 2014
Country
/Activity
C20 Production of chemi-
cals and chemical products
C21 Production of basic 
pharmaceutical products and 
pharmaceutical preparations
∑ Intramural R&D
Belgium 150 39 189
Bulgaria 6   6
Czech 71   71
Denmark      
Germany 1,089 210 1,299
Estonia 5 4 9
Ireland      
Greece 53 20 73
Spain 456 141 597
France 404 131 535
Croatia 10 8 18
Italy 404 80 484
Cyprus 3 2 5
Latvia 8 3 11
Lithuania 14   14
Luxembourg      
Hungary 22 17 39
Malta 1 5 6
Netherlands 189 39 228
Austria 97   97
Poland 108 40 148
Portugal 67 22 89
Romania 20   20
Slovenia 21 3 24
Slovakia   6 6
Finland 64   64
Sweden 59 19 78
UK      
Iceland 4   4
Norway      
Switzerland 195 64 259
*  Empty spaces – data not available 
Source: Eurostat (2017)
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Most chemical industry enterprises from Germany, 
Italy, France, Spain, and the Netherlands invest in 
intramural R&D activity. Taking this into account, 
it is important to point out the Croatian chemical 
industry and the tendency of its enterprises to im-
plement intramural R&D activities. According to 
the number of enterprises, the division of chemicals 
and chemical products that maintains intramural 
R&D activities is more dynamic in comparison with 
pharmaceutical industry enterprises. 
Table 5 Number of European chemical industry enterprises included in the implementation of extra-
mural R&D activity in 2014
Country
/Activity
C20 Production of chemi-
cals and chemical products
C21 Production of basic pharmaceutical 
products and pharmaceutical preparations
∑ Extramural 
R&D
Belgium 124 33 157
Bulgaria 12   12
Czech 71   71
Denmark 14 7 21
Germany 542 125 667
Estonia 9 4 13
Ireland 31 20 51
Greece 35 19 54
Spain 198 105 303
France 317 98 415
Croatia 12 4 16
Italy 270 69 339
Cyprus 1 2 3
Latvia 6 4 10
Lithuania 10   10
Luxembourg      
Hungary 5 9 14
Malta 0 0  
Netherlands 137 25 162
Austria 42   42
Poland 99 32 131
Portugal 32   32
Romania 0    
Slovenia 19 3 22
Slovakia   2 2
Finland 45   45
Sweden 40 16 56
UK      
Iceland 3   3
Norway 41 8 49
Switzerland 78 55 133
* Empty spaces – data not available 
Source: Eurostat (2017)
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German, Italian, French, and Spanish enterprises 
participate more actively in the implementation 
of extramural R&D activities in comparison with 
other enterprises in the European chemical in-
dustry. The general conclusion is that European 
chemical industry enterprises are more inclined 
to implement R&D activities. In this case, extra-
mural R&D activity is not a priority, but an alter-
native solution for chemical industry enterprises. 
Namely, in pharmaceutical industry activities, it 
is common to independently develop final prod-
ucts. It is notable that a greater number of chemi-
cal industry enterprises in highly developed 
countries implement intramural and extramural 
R&D activities, while former (transition) coun-
tries are characterized by a smaller number of 
this type of enterprises. Table 6 presents the share 
of enterprises from the production of chemicals 
and chemical products (C20), and production of 
basic pharmaceutical products and pharmaceuti-
cal substances (C21) with technological and non-
technological innovation in the total number of 
enterprises, according to the last available data 
for 2014.
Table 6 Enterprises with technological and non-technological innovation in the European chemical 









Belgium 16 9.9 20.2 15.9
Czech 22.7 2.6
Denmark 6.5 8.9 12 8.4
Germany 21.4 2.3 17.9 7.7
Estonia 36 0 66.7 0
Ireland 16.9 9.6
Greece 11.3 8.5
Spain 27.7 9.5 24.4 2.9
France 20.2 11.4 12.9 4.3
Croatia 9.4 5.5 18.7
Italy 18.4 9.1 30 17.9
Cyprus 0 0
Latvia 8.6 7.8 10
Lithuania 23.5 5.9 0
Luxembourg
Hungary 13.8 8.8 17.9 5.1
Malta 12.5 12.5 30 0
Netherlands 25 6.3 41.9
Austria 21.8 1.9
Poland 20 5.2 22.1
Portugal 21.4 13.5







*  Empty spaces – data not available 
Source: Eurostat (2017)
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An interesting conclusion can be reached from the 
comparison of relative values in Table 10. In gen-
eral, there is evidently a larger amount of techno-
logical innovation in comparison with non-techno-
logical innovation of chemical industry enterprises 
(division C20 and C21). In the production of chemi-
cals and chemical products the orientation towards 
technological innovation has prevailed. Among the 
enterprises from industrialized countries, there is 
an evident diﬀ erence between the share of enter-
prises with technological and non-technological in-
novation. By contrast, in the framework of (former) 
transition countries, there is an evident smaller 
diﬀ erence between the share of enterprises with 
technological and non-technological innovation. 
It is important to point out similar results in the 
framework of the pharmaceutical industry. Th ere is 
one important characteristic, namely the European 
chemical industry includes enterprises with tech-
nological innovation. Croatian enterprises are an 
exception, where most of the enterprises are with 
non-technological innovation, while in Latvia the 
shares of enterprises with technological and non-
technological innovation are close. 
Th e producers of basic chemicals do not have an 
inclination towards innovative products (unlike in 
the pharmaceutical industry), but represent a large 
and important part of the chemical industry, with a 
share of more than 54-72% in innovation process in 
total innovation activity (Albach et al., 1996). Th e 
production of synthetic ﬁ bre is characterized by a 
low level of innovativeness, which is proven by the 
small number of patent applications. Th e produc-
tion of agrochemical products (biotechnology) 
represents one of the most innovative sectors of 
the chemical industry. However, income reduction, 
complexity of long-term incubation of R&D into in-
novation and diﬃ  cult adjustment to health and en-
vironmental standards are making the achievement 
of expected results of agrochemical products pro-
duction more diﬃ  cult. Table 7 presents the produc-
tion value of enterprises in the European chemical 
industry in 2015. 
Table 7 Production value in European chemical industry enterprises in 2015
Country/ Activity
C20 Production value 
of chemicals and chemical 
products
C21 Production value of basic 
pharmaceutical products and 
pharmaceutical preparations
∑ Production 
EU28 460,000 237,891 697,891
Belgium 33,924.0 17,416.3 51,340
Bulgaria 1,412.9   1,413
Czech 5,736.3 1,301.9 7,038
Denmark 4,898.9 13,161.5 18,060
Germany 125,460.7 42,645.1 168,106
Estonia 424.0 43.9 468
Greece 2,057.2 1,080.7 3,138
Spain 33,397.5 13,611.7 47,009
France 60,758.6 34,760.6 95,519
Croatia 782.6 726.4 1,509
Italy 51,137.3 25,402.9 76,540
Cyprus 54.4 212.0 266
Latvia 223.0   223
Lithuania 1,921.9 191.7 2,114
Luxembourg 303.0   303
Hungary 5,112.5 2,917.6 8,030
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As the value rises, the use of human resources in 
the chemical industry (and its related divisions) 
becomes more eﬃ  cient. Th e indicator is adequate 
for measuring staﬀ  eﬃ  ciency for high- and medi-
um-level technology enterprises. Th e revenues of 
chemical industry enterprises are denominated in 
millions of euros, while the variable of the num-
ber of employees includes one employee per total 
achieved enterprise revenue. Th e analysis of results 
of the indicators provides the conclusion that chem-
ical industry enterprises in Germany, the Nether-
lands and the UK have the highest level of human 
resource eﬃ  ciency. 
Figure 1 presents employee productivity in Euro-
pean chemical industry enterprises for divisions 
C20 and C21 in 2014. Employee productivity is cal-
culated as a result of the ratio of gross added value 
and the employees. Th e data from 2017 refer to 
most of the EU member states (C20, C21). Data for 
Bulgaria, Latvia, Luxembourg and Sweden were not 
available (C21), nor the data for Croatia (C20, C21).
Country/ Activity
C20 Production value 
of chemicals and chemical 
products
C21 Production value of basic 
pharmaceutical products and 
pharmaceutical preparations
∑ Production 
Malta 31.3   31
Netherlands 39,676.8 4,153.3 43,830
Austria 12,846.8 4,050.6 16,897
Poland 14,409.7 3,728.6 18,138
Portugal 4,209.0 1,039.5 5,249
Romania 2,255.9 766.7 3,023
Slovenia 1,253.6   1,254
Slovakia 1,554.1 191.7 1,746
Finland   1,663.7 1,664
Sweden 7,958.4 8,995.2 16,954
UK 36,042.6 17,732.7 53,775
Source: Eurostat (2017)
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It is important to point out that the level of work 
productivity of the pharmaceutical industry ex-
ceeds the productivity in the chemical industry, 
except in the enterprises from Estonia, Lithuania, 
Norway and the Netherlands. Since the pharmaceu-
tical industry is not aﬀ ected by cyclic movements 
and achieves higher revenues in relation to the pro-
duction of chemicals and chemical products, this 
kind of result has a logical base. It can be concluded 
that there is a great diﬀ erence between the level 
of productivity of enterprises in the chemical and 
the pharmaceutical industry. Th e exception is the 
case of Irish enterprises, where work productivity 
of the pharmaceutical industry notably exceeds the 
productivity of pharmaceutical and chemical enter-
prises from other European countries. 
Th e Dutch, Norwegian and Belgian production of 
chemicals and chemical products (C20) achieves 
the highest level of work productivity. Croatian 
enterprises are ranked last but one, before the en-
terprises of the Romanian chemical industry. Th e 
highest work productivity has been recorded in the 
framework of pharmaceutical industry enterprises 
(C21) of Ireland, the United Kingdom, Denmark and 
Belgium. Th e work productivity of pharmaceutical 
enterprises from Croatia is at a higher level in com-
parison to the productivity of Croatian enterprises 
from the division C20. Croatian pharmaceutical 
enterprises are ranked in the middle of the produc-
tivity scale among the analysed countries. In order 
to calculate the eﬃ  ciency and eﬀ ectiveness of R&D 
expenditure, one must use the indicator of the ratio 
between R&D and sales revenue. In general, the re-
sults of the ratio between R&D and revenue of the 
manufacturing industry sector diﬀ er. An interest-
ing example is that of the pharmaceutical industry, 
which shows a higher ratio value compared to other 
areas of the manufacturing industry. Taking into 
account these arguments, the Figures below com-
pare the ratio results between R&D expenditure and 
achieved revenues of the two divisions (Figure 2), 
and the results of the ratio between R&D expendi-
ture and total production of the chemical industry 
in the selected European countries (Figure 3). Th e 
reference year is 2014. Th e analysed activities are 
collected from the NACE Rev. 2 classiﬁ cation. 
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Th e analysis of the results from Figure 2 indicates 
that the highest share of R&D expenditure is in the 
turnovers of the pharmaceutical industry enterprises 
(C21 – Th e production of basic pharmaceutical prod-
ucts and pharmaceutical preparations). Taking into 
account that pharmaceutical industry presents high-
technology sector, the high level of its R&D activity 
in generated revenues has a theoretical and empiri-
cal base. Th e highest share of expenditure on R&D in 
achieved turnovers has been recorded on the example 
of Bulgaria, Denmark, Croatia, Cyprus, Hungary and 
Slovenia, while the lowest ranked enterprises in the 
pharmaceutical industry come from the Netherlands, 
Estonia and Lithuania. Th e production of chemicals 
and chemical products (C20) has reached multiple 
lower shares of R&D expenditure in the achieved 
turnovers of the European chemical industry in 2014. 
It is important to point out the importance of share 
indicators for R&D in total production, which is of-
ten used in sector analysis. Th e main objective of 
calculations of the share of R&D and production is 
in the identiﬁ cation of the level of high-technology 
activity. Th e ratio results vary signiﬁ cantly among 
industries, due to diﬀ erent industrial structures. 
Countries with a large number of high-technology 
industries will have a higher relation indicator be-
tween R&D and production than the countries with 
a larger number of low-technology industries. 




























































































Th e results from 2014 can conﬁ rm the thesis that 
countries with a large number of high-technology 
industries are marked as countries with higher in-
tensity of R&D expenditure and production, unlike 
the countries with a larger number of low-tech-
nology enterprises. Th e example of the European 
chemical industry shows that countries with a nota-
ble share of the pharmaceutical industry, i.e., high-
technology industry, have the highest share of R&D 
expenditure in production. Among these countries 
are Denmark, Slovenia, Germany and Malta. On 
the other hand, chemical industry enterprises from 
Poland, Lithuania, Romania and Slovakia are char-
acterized by a relatively low ratio between R&D ex-
penditure and total production. Croatia is located 
in the middle of the scale by its R&D intensity in the 
framework of total production. 
Th ere is a large disparity in innovation activity 
among enterprises from Europe, Asia, the US, and 
the enterprises from the Middle East. Challenging 
investments in R&D increase the probability for in-
novation. Taking into consideration that R&D and 
innovation activity are very important for the chemi-
cal industry, and their importance as one of the main 
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factors of enterprises, export competitiveness can 
be conﬁ rmed. Th e majority of innovations in Euro-
pean chemical industry enterprises are products of 
enterprises’ own R&D activity, which represents the 
results of technological and innovation strategies. 
Th ere is a marked diﬀ erence in the level of innova-
tiveness among the analysed countries. Th e disparity 
in innovation activities is deﬁ ned by diﬀ erent indica-
tors of enterprises which are speciﬁ c for each ana-
lysed country. Th erefore, unequal intensity of R&D 
and innovation activity has various implications on 
export competitiveness of chemical industry enter-
prises. Also, innovativeness of the chemical industry 
of highly developed European countries is mostly 
quantitative, but prevails in terms of quality over 
(former) transition countries.   
4. Conclusion
Th e enterprises of the European chemical industry 
have been facing serious challenges, such as globali-
zation, the rise of Asian competitiveness, exchange 
rate ﬂ uctuation, an increase in prices of raw materi-
als, intensive regulation, and standardization of EU 
legislation. Th e conclusion of the analysis of the Eu-
ropean chemical industry implies that more rational 
consumption of raw materials, a higher level of in-
ternational competitiveness and environmental pro-
tection require certain postulates. Most innovation 
in European chemical industry enterprises originate 
from their own R&D activity as a result of techno-
logical and innovative enterprise strategies. Extra-
mural R&D activity is not presented as a priority, but 
as an alternative for chemical industry enterprises. 
Th e chemical industry of highly developed countries 
has a larger number of enterprises which implement 
intramural and extramural R&D activities, while the 
enterprises in certain middle-income countries and 
transition countries are usually ranked last accord-
ing to the number of enterprises. In principle, it has 
been established that there is disparity in innovation 
activity among European chemical industry enter-
prises as well as Asian, American, and Middle East-
ern chemical industry enterprises. It is important 
to consider the enterprises in the German, Belgian, 
Dutch, Austrian, French, Italian, Danish, Finnish and 
Swedish chemical industry that have the best results 
and achievements in R&D, innovation and economic 
activities. 
Th e European chemical industry should emphasise 
the importance of innovation in production and 
processes as a ﬁ nal result of R&D activity. However, 
regarding the main characteristics of the chemical 
industry sector, it is important to be aware of the 
applicability of a speciﬁ c innovation type. Consider-
ing that successful realization of product innovation 
is the main goal, it is necessary to take into account 
the risks and the need to improve the product. Eu-
ropean chemical industry enterprises can achieve 
competitive advantage only if they continuously 
invest in proﬁ table and economically viable R&D 
projects. Th e competition also implements the in-
novations that are present in European chemical 
industry processes. Th e innovation process is hard-
er to copy in terms of product innovation, which 
represents an additional competitive advantage for 
export companies of the European chemical indus-
try. Th e patent activity of the chemical industry of 
rival countries (especially China) records constant 
growth. It shows China’s strong orientation to in-
vestment into R&D activity, but also towards trans-
fer (purchase) of technology. When we consider the 
government’s security measures, the optimal level 
of cost competitiveness, the growing market and its 
geographical position, it is important to point out 
that high-level European chemical industry needs 
to focus on strengthening export competitiveness. 
Th e EU needs to provide the environment that will 
boost investment in R&D activity. In that case, the 
most sustainable course of action would be to in-
tensify ﬁ nancial support through sustainable and 
proﬁ table R&D projects, which could enhance the 
security of export competitiveness. With continu-
ous investment in specialization and education of 
current and potential R&D departments, and at the 
same time, with the awareness of the importance 
and perspectives of R&D activities, we make a step 
forward towards achieving technological advantage 
and export competitiveness of European chemical 
industry enterprises. When we generate and accept 
technological advantages, which are manifested as a 
result of eﬃ  cient investment in R&D, it is possible 
to boost the production of energy-eﬃ  cient products 
and processes that will enable sustainable develop-
ment of the European chemical industry.
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IST RAŽIVANJE I RAZVOJ I INOVACIJE KEMIJSKE 
INDUSTRIJE EU-a
Sažetak
U ovome se radu analiziraju istraživanje i razvoj, inovacije te međunarodna trgovinska aktivnost kemijske 
industrije u odabranim članicama Europske unije. U radu se provodi analiza za razdoblje od 2015. do 2015. 
godine. Metodologija je temeljena na primjeni ključnih indikatora sa svrhom postizanja objektivnih za-
ključaka radne produktivnosti i učinkovitosti proizvodnje kemikalija i proizvodnje bazičnih farmaceutskih 
proizvoda i preparata. Cilj je istraživanja analizirati europsku kemijsku industriju s gledišta istraživanja 
i razvoja i inovacija. Glavni rezultati istraživanja uključuju istraživanje i razvoj, inovativnost i rezultate 
međunarodne trgovine, stupanj tehnološkoga pozicioniranja europske kemijske industrije te preporuke i 
prijedloge za unaprjeđenje inovacijske i međunarodne konkurentnosti.  
Ključne riječi: kemijska industrija, inovacije, istraživanje i razvoj, EU, međunarodna konkurentnost
